Académique Documents
Professionnel Documents
Culture Documents
, 2012
ibuted Contrpers Pa
May 9, 201
Join our Linkedin group: University of Wisconsin Extension Services in Pharmacy Industrial Professional Development
Extension Services in Pharmacy School of Pharmacy University of Wisconsin-Madison Toll free: 877-947-4255 Email: cemail@pharmacy.wisc.edu
For program updates and to see other programs offered by Extension Services in Pharmacy, visit our website
http://ce.pharmacy.wisc.edu
NOW OPEN
CONTRIBUTED PAPER SUBMISSION SITE
Submit your Contributed Paper at www.aaps.org/2012submit
Travelships
Application Deadline: June 25, 2012
AAPS Annual Meeting and Exposition will be offering a number of travelships for its meeting held on October 1418, 2012 in Chicago. Travelships will be awarded to those who submit and have an abstract accepted to the AAPS Annual Meeting and Exposition. To submit a paper, visit www.aaps.org/2012submit. Please visit http://www.aaps.org/ awards-and-fellows for additional eligibility requirements.
NEW
VERY IMPORTANT INFORMATION
REGISTRATION REQUIREMENT = Register by September 7, 2012 NOT REGISTERED BY SEPTEMBER 7, 2012 = abstract will not be published or scheduled to present WHEN REGISTERING = provide abstract submission ID for each poster AUTHOR CHANGES = submit to abstracts@aaps.org by September 7, 2012
Submission Requirements
The following requirements must be adhered to when submitting your abstract for AAPS meetings. AAPS has implemented these policies in response to feedback from meeting participants. The most overwhelming source of dissatisfaction with past meetings has been the number of presenters who fail to show up for their presentation.
1. Conditions and Policies Persons submitting an abstract for presentation at the AAPS Annual Meeting and Exposition are doing so with the understanding that they agree to abide by the conditions and policies provided below, as well as the decisions of the Screening Committee and AAPS staff. Questions should be directed to abstracts@aaps.org. 2. Registration Requirement for Publication The presenting author is required to attend the meeting to present the paper. If the presenting author is unable to attend the meeting the co-author is responsible for the presentation. Registration is required for the author that will be presenting the paper at the meeting and the author must be registered by the Presenting Author registration deadline of September 7, 2012 or the poster will automatically be withdrawn. Withdrawn posters will not be published on the AAPS portal via Pharmaceutical Research or The AAPS Journal. If the author is working in an exhibitors booth, the authors exhibitor badge will suffice for this registration requirement. 3. Cancellation policy If the presenting author cancels his/her registration on or after September 8, 2012, AAPS will impose a $200 ($50 student) publishing fee. Registrant substitutions from the same company are allowed and may be submitted in writing at any time without penalty. If the membership status of the substitute differs from that of the original registrant, a refund or additional charge may apply. 4. Ethics Statement Final poster presentations must include the accepted abstract verbatim and should include all methods used and data resulting from the research. Actions such as omission of data from a poster presentation that was included in the submitted abstract will be considered unethical. Authors and organizations violating these requirements will be subject to penalties such as restrictions from presenting future posters.
NOTE: We are unable to accept requests to change the presentation schedule once the abstracts have been assigned. Therefore requests to change the day, time or location of your assigned presentation will not be granted. If the presenting author is unable to attend the meeting another author will be responsible for the presentation.
ABSTRACTS
Policies and Procedures
The submission system can be accessed at www.aaps.org/2012submit. If you are unable to use all the features of the site, contact your system administrator and request your system to allow cookies.
Safe Email Address/Contacts
Before beginning the abstract submission process, add abstracts@aaps.org to your email address/contacts list.
Screening/Presentation
Final assignment to poster sessions will be made at the discretion of the screening committee.
Permissions/Clearances
It is the responsibility of the author(s) to obtain the necessary permissions and clearances for all research prior to submission of the abstract. AAPS assumes no liability or responsibility for the publication of any material that is submitted.
Notification of Acceptance/Rejection
Status notifications will be sent via email on June 8, 2012. Notification and other correspondence will be sent to the abstract submitter, main author and presenting author. If there is a change in presenting author after the final submission deadline, contact AAPS at abstracts@aaps.org.
Acceptance Criteria
Acceptance of the abstract for presentation will be based on the concise, accurate presentation of new data. It is imperative that data is presented in the results section so the AAPS screeners can judge the scientific value of your abstract. Include all research information, data, charts and graphs in your submission so that it can be reviewed in its entirety. All papers will be scheduled by the Screening Committee.
Provisional Acceptance
A provisional acceptance is granted to an abstract that is acceptable for presentation, but does not adhere to the formatting guidelines set forth in the Call for Papers. The author is given the opportunity to correct the formatting, spelling, grammar, or symbols. Revisions are required within 5 days of receipt of the notification. Deadline for receipt of revised abstracts is June 14, 2012. If AAPS has not received the revised abstract by this date, the abstract will automatically be rejected. The Appeals Process does not apply to provisionally acceptance abstracts.
Rejection Criteria
Criteria for rejection include lack of data, commerciality, inconsistent or ambiguous data, reviews of literature, lack of novelty or innovation, stating that information will be included in the poster, previously published, but not acknowledged (see Encore Presentation), or failure to follow format guidelines (Purpose, Methods, Results, and Conclusion). The submission of multiple abstracts covering the same or similar work is discouraged. Authors must submit one strong abstract instead of several abstracts presenting the same work.
Abstract Revisions
Revisions can be made at any time before the submission deadline. Proofread, spell-check and make sure all authors are listed on your abstract before submitting as the abstracts will be printed exactly as they appear when submitted. If you revise your submission you must repeat all submission steps. Failure to complete all the steps will result in an incomplete submission and your abstract will not be sent to the Screening Committee. Revisions cannot be made after the submission deadline of May 9, 2012. Please do not contact AAPS to receive a deadline extension. Deadline extensions cannot be granted under any circumstance.
Encore Presentations
You are invited to submit papers that were presented at a nonAAPS meeting after March 1, 2012. Please indicate the following with your submission: 1. Indicate the submission is an Encore Presentation. 2. The name of the meeting at which the paper was originally presented. 3. Indicate the date the paper was originally presented. No papers presented before March 1, 2012 will be accepted as Encore Presentations. Encore Presentation submissions will be screened under the same criteria as other contributed papers.
Abstract Withdrawal
To withdraw your abstract, written notification must be sent to abstracts@aaps.org. You may withdraw your poster at anytime, however due to publishing deadlines, withdrawal notifications must be received by September 7, 2012 to ensure withdrawal from online publication and the final program. This notification must be from the submitter of the abstract and should include the abstract title, authors, the abstract confirmation number, and the name, phone number and email of the person making the request. AAPS will acknowledge all withdrawal notifications by email.
ABSTRACTS
Submission Instructions
The submission system can be accessed at www.aaps.org/2012submit. Create a user account by either selecting New User or Create New User with AAPS Member ID. Non-members should click on the New User link. Enter the information requested on the Login Information page. Then click Enter, your login and password will be sent to the email address you provided. AAPS members should click on the Create New User with AAPS Member ID link. Next, a prompt will appear asking for the membership identification number. Once this is supplied, all of the necessary contact information is automatically entered. If you do not know your membership identification number, contact AAPS at +1.877.998.2277 for assistance.
1 2 3
(Note: Do not use ALL CAPS at any time during the submission process.) COPYRIGHT: Read and acknowledge the Copyright.
AUTHORS: When adding your authors you must designate a Presenting Author and a Main Author. All correspondence will be sent to the submitter, main author and presenting author you will need these email addresses for submission of your abstract. One author can be designated as both the main author and the presenting author. The authors can be in any order you designate and the arrows in the Promote/Demote columns allow the order to be rearranged. Enter first names only in the First Name Box. Enter your full middle name in the Middle Name Box. Enter last name or family name in the Last Name Box. If your last name is hyphenated, include the hyphen between the two names. Enter any middle or secondary name(s) in the Middle Name Box. It is important to use these boxes correctly or your author name(s) will not appear in the correct order for the List of Authors in the Final Program. When finished, click on the Finished Adding Authors link. This is the only place you enter your author information. ABSTRACT: We have made changes in the submission process. You can no longer upload a word document. You must copy and paste your text from a word document into the text boxes for Purpose, Methods, Results, and Conclusion. Do not include the headings Purpose, Methods, Results, and Conclusion in your copied text for the text boxes.
4. Upload Graphics your graphics must be in jpg or gif file formats and will automatically be resized to the submission site specifications. Images will appear with a maximum height of 200 pixels. The width of the image will depend on how many images you upload. You may upload no more than three (3) graphic files for your abstract. Include a caption for the graphic as part of the image (example: Table 1 or Image 2). Once you have uploaded your image(s)/graphic(s), click on the Finished Adding Images button. Make sure your graphic is legible during the Proofing Stage. 5. Select Preview to proof your abstract. Carefully review the proof for format, spelling, grammar, and special characters. Close the preview window and make edits if necessary. Once satisfied the abstract is complete, select Continue.
4 5 6
ABSTRACT DETAILS: Select the Primary Topic from the pull-down menu. From Subtopic section pull down menu make the selection that is most relevant to your submission. The pull down menu for the Sub-topic is only available for the Primary Topic you have selected.
*ALL PRIMARY TOPICS WILL HAVE A SUBTOPIC, HOWEVER NOT ALL SUBTOPICS WILL HAVE A SECONDARY TOPIC. IF A SUBTOPIC DOES NOT HAVE A SECONDARY TOPIC, THEN PROCEED TO THE NEXT STEP. A FULL LIST OF PAPER TOPICS IS ON PAGES 89.
Answer the Are you a Student question. If you are a student, you will be asked to supply the name and email address of your Primary/ Principal Investigator. PROOFREAD: Click Proofread button to review your submission to confirm that it is complete. If satisfied, close the proofread box and select Accept My Abstract. If you want to make changes, select Resubmit My Abstract. If you do not want to choose either of these options you can log off and return later. In the upper left hand corner there is a link to Logoff. Proofread your abstract before you accept it. No changes can be made after the submission deadline of May 9, 2012.
If you include graphics or tables in your abstract, the images must be in jpg or gif file format. A limit of three (3) images may be uploaded for your abstract. Image labels or captions such as Table 1 or Image 1 should be included in the image file. 1. Fill in the Title Do not use ALL CAPS in the title or any portion of the abstract. This is the only place you enter your title. 2. Fill in the Purpose, Methods, Results, and Conclusions. There is a 350 word limit, excluding the title and authors, so you will need to defer to the counts at the bottom of this screen. Do not include the headings in your copied text for each box. 3. Special Characters if your abstract contains symbols or special characters, please make sure they are converted correctly during the proofing stage. The table on the right shows the available symbols/characters. If these do not convert into the pdf properly, go back to the text boxes and use the table by clicking on the symbol while your cursor is in the appropriate place within the text. This will insert html code for the symbol. Once you have completed this, proof your abstract again.
SUBMIT YOUR PAPER: You must click Accept My Abstract in order to successfully complete the submission process.
Technical Help
If you have any questions or are experiencing difficulties in the submission process, contact AAPS at abstracts@aaps.org. NOTE: Do not send abstracts directly to the screeners. Abstracts must be submitted according to the Call for Papers.
Chemical Biology and Highthroughput Screening Combinatorial Synthesis Computational Chemistry Drug Development for Specific Targets/Receptors Drug Discovery High Throughput Screening Molecular Diversity Natural Products Peptides, Oligonucleotides, Haptens Rational Drug Design Structure Activity Relationships Other
Oral, Controlled Release DRUG DELIVERY PHARMACEUTICAL TECHNOLOGIES (SMALL MOLECULE) Oral, Immediate Release cont...
Parenteral
Physical Pharmacy Process Analytical Technologies Process Scale-up QbD in Formulation Design Solubility Enhancement Stability Programs Transdermal
In Vivo-In Vitro Relationships/CorDRUG DELIVERY BIOPHARMACEUTICS relations (see In Vitro Methods) Large Molecule Controlled Release Strategies Devices Mechanism-based Drug Design Nasal and Pulmonary Other Parenteral Targeted Drug Delivery & Prodrugs Transdermal Devices Mechanism-based Drug Design Nasal and Pulmonary Oral Other Parenteral Targeted Drug Delivery & Prodrugs Transdermal Active Passive
Formulation Manufacturing Discovery Formulation Discovery Formulation Manufacturing Discovery Formulation Manufacturing
Other
Small Molecule
Biochemical Assay Related Issues (see Primary Topic: Analytical Methodology) Cell-based Therapeutic Mechanisms/Actions Effects of Fermentation, Cell Culture, Recovery, etc. Formulation
Apoptosis and Signal Transduction Growth Factors and Cytokines Transporter/Receptor Regulation
Transmembrane Permeability Issues Transporters (related to Drug Delivery) Other Aerosols DRUG DELIVERY PHARMACEUTICAL TECHNOLOGIES (SMALL MOLECULE)
Novel Therapeutics
Dermal/Topical
Devices
Nanotechnology
Discovery Formulation Manufacturing Discovery Formulation Manufacturing Discovery Formulation Manufacturing Discovery Formulation Manufacturing Discovery Formulation Manufacturing Discovery Formulation Manufacturing
Characterization Design and Manufacture QC Issues and Design Space Stability Artificial Chromosomes Gene Therapy Non-viral NRNA Oligos Stem Cells Viral Virus-like Particles
ANALYTICAL METHODOLOGY
Chromatographic Approaches Immunochemistry Approaches Activity Assessment Immunogenicity Other In Vivo-In Vitro Relationships/ Correlations Method Development and Validation
PRIMARY TOPIC
SUBTOPIC
SECONDARY TOPIC
PRIMARY TOPIC
SUBTOPIC
SECONDARY TOPIC
HPLC (Large Molecule) HPLC (Small Molecule) Hyphenated Methods Large Molecule (e.g., GC-MC,LC-MS, etc.) Hyphenated Methods Small Molecule (e.g., GC-MC, LC-MS, etc.) Immunoassay
Biological Matrix Non-biological Matrix Biological Matrix Non-biological Matrix Biological Matrix Non-biological Matrix Biological Matrix Non-biological Matrix Emerging Technologies Immunogenicity PK Samples
Theoretical and Statistical Aspects of Method Validation Microdialysis Methods Proteomics-protein Chip Ligand Binding Assays Sample Preparation Strategies Biological Matrix Non-biological Matrix Spectroscopic Techniques Biological Matrix Non-biological Matrix Stability Programs Other Biological Matrix Non-biological Matrix
Pharmacoeconomics Outcomes Research Pharmacokinetics (see Primary Topic Pharmacokinetics/ Pharmacodynamics) Pharmacotherapy Population Kinetics (see Primary Topic Pharmacokinetics/ Pharmacodynamics) Special Patient Populations Elderly Hepatic Other Pediatrics Renal Therapeutic Drug Monitoring Other Identification and Diagnostics Measurement Role in Clinical Pharmacology and Translational Research Translational Research Other
BIOMARKERS
PHARMACOKINETICS/ PHARMACODYNAMICS
Bioavailability
First Pass Effects/Drug Absorption Food Effects Formulation Effects Preclinical Clinical In Vitro Preclinical Clinical In Vitro Preclinical Clinical Trial Simulation DNA Microarray/Gene Chips Methodologies Modeling and Predictions Pharmacogenetics and Polymorphism (SNPs)
Drug Metabolism
Quality Systems
Other
REGULATORY AFFAIRS
Other
Adverse Events Biostatistics Clinical Data Management Conduct Drug Interactions Management Regulatory Issues
Biosimilars cGMP Chemistry, Manufacturing and Control (CMC) Clinical Trial CTD Dossier Environmental Concerns ICH Inspections Intellectual Property Marketing Pharmacovigilance Regulations/Guidance Safety/Efficacy Specifications Stability and Shelf-life Other
OTHER
2012 AAPS Annual Meeting and Exposition
FAQs
Q: How do I submit author names?
A: See Step 2 of Six Steps to the Successful Submission of Abstracts. To avoid errors be consistent with author names, i.e., John J. Doe; not John Doe, John J. Doe and J.J. Doe.
Q: Does AAPS provide grants or scholarships for student authors presenting a poster at the meeting?
A: No. However student authors may apply for a Travelship or for a Graduate Student Symposium award. Details regarding travelships and awards can be found on the annual meeting website at www.aaps.org/inside/awards_fellows.
Q: What happens if the presenting author is not registered by the presenting author registration deadline.
A: All abstracts, where the presenting author is not registered by September 7, 2012, will be automatically withdrawn from scheduling and will not be published.
Jayachandra B. Ramapuram
Auburn University
MSE SECTION
Raman M. Iyer
Hoffmann-La Roche, Inc.
MSE SECTION
Sharon R. Pichon
AAPS
Teresa Homrich
abstracts@aaps.org Abstract Manager, AAPS 2107 Wilson Boulevard, Suite 700 Arlington, VA 22201 PH: +1.703.248.4792 FX: +1.703.243.5582
10